Actuate Therapeutics Financial Ratios for Analysis 2023-2024 | ACTU

Fifteen years of historical annual and quarterly financial ratios and margins for Actuate Therapeutics (ACTU).

Annual Data

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share
2023
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
0.00
-

Quarterly Data

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share
2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-30
1.680.03----
------
--0.06----
------
------
------
------
------
------
------
------
------
------
-111.435.75----
-111.435.75----
-41.86-379.72----
-111.435.75----
0.27-4.63----
-1.58-5.060.000.00-10.95-7.37
-1.58-5.06---10.95-7.37